RecruitingNot applicableNCT07437391
Effect of L-Carnitine Supplementation in Preterm Neonates
Studying Neonatal acute respiratory distress syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Muhammad Aamir Latif
- Principal Investigator
- Muhammad Sarfraz, FCPSRecep Tayyip Erdogan Hospital, Muzaffargarh
- Intervention
- L-carnitine(drug)
- Enrollment
- 160 target
- Eligibility
- All sexes
- Timeline
- 2026 – 2026
Study locations (1)
- Recep Tayyip Erdogan Hospital/Indus Hospital & Health Network, Muzaffargarh, Punjab Province, Pakistan
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07437391 on ClinicalTrials.govOther trials for Neonatal acute respiratory distress syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07154134Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress SyndromeTanta University
- RECRUITINGNCT06874478Respiratory Distress and Elective Cesarean Section at TermAssiut University
- RECRUITINGPHASE4NCT06074380Non Inferiority Trial Investigating Surfactants Administered Via MISTEndeavor Health
- RECRUITINGNCT06031324The Role of Lung Ultrasonography Score in Predicting Prognosis in Term and Late Preterm Newborns With Postnatal Respiratory DistressBursa City Hospital
See all trials for Neonatal acute respiratory distress syndrome →